ArticleMolecular cancer therapeutics2023

Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug Conjugate.

Patrick G Groothuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.